Indeed, blocking Kv1.3 with PAP‐1 reduced microglia activation and overall brain levels of the inflammatory cytokines IL‐1β and IFN‐γ, leading to smaller infarct areas and improved neurological deficit scores in a mouse model of ischemic stroke (Chen et al., 2018). The gene discussed is IFNG; the disease is ischemic stroke.